Stay updated on Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.

Latest updates to the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the older v3.5.3 entry was removed.SummaryDifference0.1%

- Check9 days agoChange DetectedThe trial's recruitment status updated from Recruiting to Active, not recruiting. The record is augmented with key sections (Contacts/Locations, Study Design, Study Status, and Recruitment Status) to present current study details and contact information.SummaryDifference0.7%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a software/version change rather than any change to the clinical trial record.SummaryDifference0.1%

- Check30 days agoChange DetectedA new revision (v3.5.2) dated 2026-04-13 adds Oversight and Study Status to the record history; the previous revision (v3.5.0) dated 2025-10-09 is removed.SummaryDifference0.5%

- Check59 days agoChange DetectedRevision v3.5.0 was added and v3.4.3 was removed from the history.SummaryDifference0.1%

- Check66 days agoChange DetectedA new version entry, Revision: v3.4.3, was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.